The applications of 3D printing in the medical field continue to expand.
26-01-12
In today’s era of rapid advances in medical technology, 3D printing, with its unique manufacturing advantages, is penetrating every facet of the healthcare sector at an unprecedented pace. From the fabrication of personalized implants and the planning of complex surgical procedures to tissue engineering and drug discovery, the scope of its applications continues to expand, ushering in a revolutionary transformation of modern medicine.
The orthopedic field is one of the most mature and widely adopted markets for 3D printing technology. Traditional orthopedic implants are typically designed according to standardized specifications, making it difficult to achieve precise anatomical matching with individual patients, which often leads to a high incidence of postoperative complications and prolonged rehabilitation periods. In contrast, 3D printing leverages precise scanning of patient skeletal data to generate a 1:1 digital model, which is then directly fabricated using metal additive manufacturing processes—such as selective laser melting (SLM)—to produce personalized implants that fit the patient’s anatomy with exceptional accuracy. For example, in hip arthroplasty, 3D-printed titanium alloy acetabular cups feature a porous structure that promotes bone ingrowth, thereby significantly enhancing the long-term stability of the prosthesis. Clinical data show that patients receiving 3D-printed orthopedic implants experience an approximately 30% reduction in postoperative complication rates and an average shortening of the rehabilitation period by more than 15%. Domestic companies such as Aikang Medical and Chunli Medical have already achieved mass production of 3D-printed hip and knee implants and obtained approval from the National Medical Products Administration (NMPA) for market release, marking the official transition of this technology into widespread clinical application.
The dental field represents another untapped frontier for the application of 3D printing technology. With the widespread adoption of digital dental workflows, intraoral scan data can be directly imported into 3D printing systems, enabling a seamless end-to-end process from design to finished restoration. Stereolithography (SLA) and digital light processing (DLP) technologies dominate the mid- and low-end markets, primarily for fabricating crowns, implant guides, and other restorations, while selective laser melting (SLM) is geared toward high-end restorative applications, such as titanium alloy implant-supported bridges. Invisible orthodontic brands like Invisalign rely on large-scale 3D printing to produce master models for aligners, with daily print volumes reaching hundreds of thousands of units, thereby significantly boosting production efficiency. Domestic companies such as Shining 3D and Yuerui 3D have developed end-to-end digital dental solutions that cover the entire workflow—from scanning and design to printing—driving the annual compound growth rate of the dental 3D-printing market to over 17%. By 2027, China is projected to become the world’s largest consumer market for dental 3D-printing equipment and materials.
In the cardiovascular field, 3D printing is advancing from preoperative planning to the fabrication of functional implants. In cases such as complex congenital heart disease and aortic aneurysms, clinicians can print patient-specific, true-to-scale models of the heart and vasculature, enabling intuitive assessment of lesion anatomy, simulation of surgical approaches, and improved success rates for interventional procedures. For example, Johns Hopkins Hospital has used 3D-printed models to assist in congenital heart surgery, reducing average operative time by 27 minutes and decreasing contrast agent usage by 35%. Domestically, institutions such as the Shanghai Children’s Medical Center and Beijing Fuwai Hospital have also adopted 3D-printing–based preoperative planning, significantly lowering surgical risks in infants and young children. Moreover, bio-3D printing has achieved breakthroughs in tissue-engineered cardiac valves and biodegradable vascular stents; research teams have successfully constructed bioactive valve prototypes in vitro, and animal studies have demonstrated robust tissue regeneration within six months. Although no 3D-printed cardiac implants have yet been approved for clinical use, advances in stem-cell culture, biomaterial ink development, and multi-material printing hold promise that, over the next decade, functional myocardial patches and fully bioengineered artificial hearts will be translated into clinical practice.
In addition to the aforementioned areas, 3D printing technology also holds tremendous potential in soft-tissue repair, cancer treatment, and drug development. For instance, for patients with tracheobronchomalacia (TBM), custom-made 3D-printed splints can provide structural support to the collapsed airway, facilitating complete recovery. During tumor-resection surgeries, 3D-printed tumor models help surgeons precisely delineate the extent of resection, thereby minimizing damage to healthy tissue. In drug development, 3D printing can fabricate drug-delivery systems with intricate internal architectures, enabling targeted and controlled drug release. Moreover, driven by advancements in 5G and the Internet of Things, medical 3D printing is evolving toward remote surgical guidance and cloud-based data sharing, further enhancing application efficiency and service quality.
However, the expansion of 3D printing applications in healthcare continues to face numerous challenges. High equipment costs, a shortage of skilled personnel, and an underdeveloped standardization framework all constrain the industry’s move toward large-scale deployment. For instance, high-end metal 3D printing equipment relies heavily on imports, with low domestic production rates for critical components such as high-power lasers and galvanometer scanners. Meanwhile, the regulatory approval process for 3D-printed medical devices still requires further refinement to ensure their safety and efficacy. Despite these hurdles, increasing policy support, breakthroughs in technological innovation, and coordinated development across the upstream and downstream segments of the value chain are poised to unlock vast potential for 3D printing in healthcare. Looking ahead, this technology holds the promise of transformative advances in personalized medicine, precision treatment, and medical-device innovation, ultimately delivering higher-quality, more efficient care to patients worldwide.
Previous article
Next Article
Related News
The applications of 3D printing in the medical field continue to expand.
In today’s era of rapid advances in medical technology, 3D printing, with its unique manufacturing advantages, is penetrating every facet of the healthcare sector at an unprecedented pace—ranging from the fabrication of personalized implants and the planning of complex surgical procedures to tissue engineering and drug discovery. Its applications continue to expand, ushering in a revolutionary transformation of modern medicine.
Unlocking the Full-Chain Value of 3D Printing
Amid the wave of transformation and upgrading in manufacturing, 3D printing—with its disruptive “digital-to-physical” manufacturing paradigm—is reshaping the global industrial landscape. From aerospace to biomedicine, from consumer electronics to construction, 3D printing has moved beyond prototype development and is now advancing toward the large-scale production of end-use parts. By 2025, the global 3D-printing market is projected to exceed US$21.9 billion, with China leading the Asia-Pacific region at a compound annual growth rate of 27%. This remarkable growth is underpinned by collaborative innovation across the entire value chain and a fundamental reconfiguration of industry value.
Amid the sweeping transformation of manufacturing toward intelligence and sustainability, 3D printing is boldly redefining the boundaries of traditional manufacturing. Spanning industries from aerospace and consumer electronics to personalized healthcare and architectural innovation, this technology—which builds objects layer by layer based on digital models—has not only achieved breakthroughs in scalable mass production but also accelerated the adoption of additive manufacturing in the consumer electronics sector through key advantages such as enhanced material utilization and streamlined process workflows.
The Era of Consumer-Grade Continuous-Fiber 3D Printing
Amid the ongoing wave of breakthroughs in 3D printing technology, consumer-grade continuous-fiber 3D printing is making a disruptive entry into the public eye. Once regarded as an industrial-only capability, this technology is now moving from the laboratory to home workstations—thanks to technological innovation and cost reductions—thereby redefining the boundaries of “personalized manufacturing.”
Beijing Yunshang Intelligent Manufacturing Technology Co., Ltd.
Hotline(24 hours a day)
Headquarters Address: Room 708, Building 2, HICOOL Industrial Park, Nanfaxin, Shunyi District, Beijing
Follow
Customer service WeChat
WeChat Official Account
COPYRIGHT 2026 Beijing Yunshang Intelligent Manufacturing Technology Co., Ltd.
Powered by 300.cn Privacy Policy
YUNS-123456
Smart Customer Service
WhatsApp：864009005667
Company email：support@chinayuns.com
Telephone：400 900 5667